Supercharging A New FDA: Marty Makary on Science, Power & Patients
Key initiatives include streamlining clinical trial processes, reducing animal testing, reforming vaccine schedules to focus on core essentials, and shifting food guidelines toward protein while eliminating artificial dysummaryAnimal Testing Reduction: The FDA has eliminated the requirement for chimpanzee studies for monoclonal antibodies, citing low statistical power and misleading data. They are replacing animal models with computational modtakeaway“90% of drugs that pass animal studies do not pass safety and efficacy in humans. So what are we doing? We have computational modeling now... and we have something called organ on a chip technology.”quote
